跳至主要内容
临床试验/NCT02614885
NCT02614885已完成不适用

Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue

Innoblative Designs, Inc.0 个研究点目标入组 11 人开始时间: 2016年7月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11
主要终点
Histologic measurement of cavitary ablation lesions created by the Innoblative radiofrequency ablation device in ex vivo breast tissue to correlate ablation size with ablation parameters.

研究概览

简要总结

This is a single-arm, prospective study of a radiofrequency ablation device on the excised breast tissue of ten (10) prophylactic mastectomy patients. The ablation lesion created by the device will be analyzed histologically.

详细描述

This study is a single-center, prospective, open label study of a radiofrequency ablation device. 10 patients who are scheduled to undergo prophylactic mastectomy will be recruited by the clinical investigators at the investigational site in accordance with the inclusion and exclusion criteria. Once the breast tissue is removed, the radiofrequency ablation device will be used on the ex vivo tissue to ablate a lesion around a cavity created in the tissue. The ablation lesion will be characterized. The study period per subject is the time it takes to assess the ablation lesion histologically.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • At least 18 years of age
  • Scheduled to receive a standard of care prophylactic mastectomy (or prophylactic bi-lateral mastectomy)
  • The patients' breast(s) to be included in the study are undiseased
  • The patient has adequate breast volume for ex vivo ablation procedure

排除标准

  • The patient is receiving a skin sparing mastectomy(s)
  • The patient has had previous exposure to chemotherapy or radiation therapy
  • The patient has implants in the breast(s) to be included in the study
  • The patient is currently pregnant or lactating
  • The patient has tissue markers implanted in the breast to be included in the study (unless these can be removed when creating a cavity in the ex vivo breast tissue)
  • The patient has had previous surgery on the breast(s) to be included in the study (unless study investigator determines that this will not affect the validity of data in this study)
  • The patient in participating in any other clinical study of a device or drug that may impact the participant safety of the validity of data acquired in this study

结局指标

主要结局

Histologic measurement of cavitary ablation lesions created by the Innoblative radiofrequency ablation device in ex vivo breast tissue to correlate ablation size with ablation parameters.

时间窗: Two weeks after surgery

Histologic analysis of ablation depth around the cavity.

次要结局

未报告次要终点

研究者

发起方
Innoblative Designs, Inc.
申办方类型
Industry
责任方
Sponsor

相似试验